| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/04/1997 | CA1338892C Process for the preparation of enantiomerically homogeneous aminopyrrolidinyl naphthyridine and quinolone carboxylic acids |
| 01/30/1997 | WO1997003345A2 Detection and quantification of human herpesvirus 7 by enzymic amplification dna virus dna |
| 01/30/1997 | WO1997003211A1 Antisense inhibition of hepatitis b virus replication |
| 01/30/1997 | WO1997003188A2 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 01/30/1997 | WO1997003187A2 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 01/30/1997 | WO1997003083A1 Pyrimidine nucleoside derivative |
| 01/30/1997 | WO1997003082A2 Pyrimidine nucleoside derivatives |
| 01/30/1997 | WO1997002840A1 Immunovectors for the intracellular and intranuclear transport |
| 01/30/1997 | WO1997002836A1 Clostridium difficile toxins as mucosal adjuvants |
| 01/30/1997 | WO1997002821A2 Antifungal agent, compound therefor, process for producing the same |
| 01/30/1997 | CA2226362A1 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 01/30/1997 | CA2226339A1 Clostridium difficile toxins as mucosal adjuvants |
| 01/30/1997 | CA2226096A1 Pyrimidine nucleoside derivatives |
| 01/30/1997 | CA2223645A1 Antisense inhibition of hepatitis b virus replication |
| 01/29/1997 | EP0755684A1 Vaccine conjugate |
| 01/29/1997 | EP0755675A1 Dermatological and/or pharmaceutical composition, process of preparation and utilization |
| 01/29/1997 | EP0755441A1 Antibacterial therapy with genotypically modified bacteriophage |
| 01/29/1997 | EP0755440A1 Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
| 01/29/1997 | EP0755403A1 Method of separating protective components of bordetella pertussis |
| 01/29/1997 | EP0755393A1 Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4- 3-(1-methylethylamino)-2-pyridinyl]piperazine |
| 01/29/1997 | EP0755386A1 Benzamide derivative, compositions containing said derivative and use thereof |
| 01/29/1997 | EP0755372A1 Inhibitors of influenza virus neuraminidase and methods of making and using the same |
| 01/29/1997 | EP0755262A1 Composition for the treatment of lung disease |
| 01/29/1997 | EP0755259A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON |
| 01/29/1997 | EP0727978A4 Topical aromatic releasing compositions |
| 01/29/1997 | EP0698012B1 Use of deoxygalactonojirimycin derivatives for inhibiting glycolipid synthesis |
| 01/29/1997 | EP0652755B1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
| 01/29/1997 | EP0594702B1 Substituted indoles as anti-aids pharmaceuticals |
| 01/29/1997 | EP0571491B1 Benzopyran phenol derivates for use as immunostimulating agents |
| 01/29/1997 | CN1141637A Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/29/1997 | CN1141634A Process and intermediates for preparing naphthycidonecarboxylic acid salts |
| 01/29/1997 | CN1141196A Application of quinoxalines in combination with protease inhibitors as medicaments |
| 01/29/1997 | CA2182226A1 Dermatological or pharmaceutical composition; process for preparing and uses |
| 01/28/1997 | US5597898 NF-κB activation regulatory protein, IκB-β |
| 01/28/1997 | US5597721 Preparation of antigens of and of vaccines for the virus of mystery disease, antigens and vaccines obtained for the prevention of this disease |
| 01/28/1997 | US5597715 7,42-Bis(O-demethyl)rapamycin |
| 01/28/1997 | US5597709 Human growth hormone splice variants hGHV-2(88) and hGHV-3(53) |
| 01/28/1997 | US5597708 Cloning of a malarial gene |
| 01/28/1997 | US5597565 Antibiotics for biological control of post harvest diseases |
| 01/23/1997 | WO1997002355A1 Recombinant mva virus, and the use thereof |
| 01/23/1997 | WO1997002351A1 Recombinant protein having bacteriophage endosialidase enzymatic activity |
| 01/23/1997 | WO1997002344A2 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 01/23/1997 | WO1997002342A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 01/23/1997 | WO1997002288A1 Purification of dalbaheptide antibiotics by isoelectric focusing |
| 01/23/1997 | WO1997002287A1 Parevins and tachytegrins |
| 01/23/1997 | WO1997002286A1 Novel antibiotic peptides |
| 01/23/1997 | WO1997002254A1 Quinazoline derivatives |
| 01/23/1997 | WO1997002244A1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 01/23/1997 | WO1997002039A1 Antibacterial synergistic composition comprising rifabutin |
| 01/23/1997 | WO1997002034A1 Anti-infection, anti-inflammatory and anti-tumour drug |
| 01/23/1997 | WO1997002028A1 Inactivation of pathogens using hydroxymethylamines |
| 01/23/1997 | WO1997002026A1 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases |
| 01/23/1997 | WO1997002021A1 Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors |
| 01/23/1997 | WO1997002020A1 Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole |
| 01/23/1997 | WO1996040945A3 Nucleic acid respiratory syncytial virus vaccines |
| 01/23/1997 | WO1996040940A3 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 01/23/1997 | CA2587000A1 Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole |
| 01/23/1997 | CA2226258A1 Recombinant protein having bacteriophage endosialidase enzymatic activity |
| 01/23/1997 | CA2226121A1 Parevins and tachytegrins |
| 01/23/1997 | CA2223825A1 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 01/23/1997 | CA2198085A1 Inactivation of pathogens using hydroxymethylamines |
| 01/22/1997 | EP0754702A2 Cyclopentane-beta-amino acid-tripeptides |
| 01/22/1997 | EP0754688A2 Dioxolane intermediates |
| 01/22/1997 | EP0754687A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/22/1997 | EP0754678A2 Improvement of physiological tolerance of pharmaceutical active beta-amino acids |
| 01/22/1997 | EP0754242A1 OLIGONUCLEOTIDE N3'$m(7)P5' PHOSPHORAMIDATES: SYNTHESIS AND COMPOUNDS; HYBRIDIZATION AND NUCLEASE RESISTANCE PROPERTIES |
| 01/22/1997 | EP0754234A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICE rel-II) |
| 01/22/1997 | EP0754231A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 01/22/1997 | EP0754228A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY |
| 01/22/1997 | EP0754223A1 Non-pathogenic strains of hiv-1 |
| 01/22/1997 | EP0754193A1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure |
| 01/22/1997 | EP0754188A1 Oligonucleotides with anti-cytomegalovirus activity |
| 01/22/1997 | EP0754180A1 Anti-helicobacter ester and carbamate derivatives of azolones |
| 01/22/1997 | EP0754061A1 New oral pharmaceutical dosage form |
| 01/22/1997 | EP0754057A1 COMPOSITIONS AND METHODS FOR VACCINES COMPRISING $g(a)-GALACTOSYL EPITOPES |
| 01/22/1997 | EP0754055A1 Group a streptococcal polysaccharide immunogenic compositions and methods |
| 01/22/1997 | EP0754053A1 Novel hemostatic composition |
| 01/22/1997 | EP0754052A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound |
| 01/22/1997 | EP0754050A1 Anti-gram-positive bacterial methods and materials |
| 01/22/1997 | EP0754049A1 Anti-fungal methods and materials |
| 01/22/1997 | EP0754047A1 Injectable solutions of dirithromycin |
| 01/22/1997 | EP0699187B1 Beta,beta-dimethyl-4-piperidineethanamine derivatives as inhibitors of the cholesterol biosynthesis |
| 01/22/1997 | EP0687177B1 Use of lamotrigine for treating aids-related neural disorders |
| 01/22/1997 | EP0677048B1 Cyclic sulfone containing retroviral protease inhibitors |
| 01/22/1997 | EP0553106B1 Anticoccidial and growth promoting polycyclic ether antibiotic |
| 01/22/1997 | EP0504290B1 Inhibitors of pneumocystis carinii dihydrofolate reductase |
| 01/22/1997 | CN1141060A Haemophilus transferrin receptor genes |
| 01/22/1997 | CN1141059A P53-binding polypeptides and polynucleotides encoding same |
| 01/22/1997 | CN1141045A Monohydrate of (E)-2'-deoxy-2'-(fluoromethylene) cytidine |
| 01/22/1997 | CN1141033A DP-IV-serine protease inhibitors |
| 01/22/1997 | CN1141002A Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 01/22/1997 | CN1141000A Vaccine design and production |
| 01/22/1997 | CN1140999A Anti-fungal methods and materials |
| 01/22/1997 | CN1140992A Flavin derivatives as anti-viral agents |
| 01/22/1997 | CN1140714A Preparation of cephalosporin antibiotic using syn-isomer of thiazolyl intermediate |
| 01/22/1997 | CN1140606A Ointment for treatment of tinea pedis |
| 01/22/1997 | CN1140602A Medicine for treatment of tuberculosis |
| 01/22/1997 | CN1140601A Traditional-Chinese-medicines antiphthitic preparation |
| 01/22/1997 | CN1033866C Recombinant DNA-derived Bordetella toxin subunit analogs |
| 01/22/1997 | CN1033865C Cell-associated glucosyltransferase, antibody thereto, and dental caries prophylactic composition contg. said antibody as effective component |